At just after 2am, paramedics found him dead.
He wasn't told he should keep his door open, so the fire brigade had to break the door. The one sent to him had to come from 60 miles away. An ambulance was allocated to him at 12.30am, but that crew was diverted to another call. 'He knew all of us - his children and grandchildren - would have been asleep so didn't ring us. When asked if he felt as though an elastic band was pressing across his chest, he said it did. He said he thought he was having a heart attack, though he had no history of cardiac problems. Ava has listened to his emergency call made in May, when he sounded 'calm, not panicking'. One reader, Ava Sanderson, tries not to think about what her father James, 66, 'an avid golfer and a robust man', went through in his last hours at the Surrey flat where he lived by himself. And medical charities are now warning that heart and stroke patients could die unnecessarily or be left permanently disabled after suffering long delays in getting medical attention. Scores of harrowing replies revealed the devastating impact on patients and their loved ones. Moderna says it is not seeking to stop the sale of the Pfizer shot or have it removed from the market - but instead to receive damages for patent infringement.Īfter highlighting Britain's worsening ambulance crisis last week, The Mail on Sunday asked readers to get in touch with their experiences. Moderna follows just behind, projecting $19 billion in global Covid vaccine sales this year. Pfizer alone is projected to earn around $32 billion in sales of its shot around the world - with the figure likely to increase with the soon-to-be approval of its Omicron-specific shot. Pfizer and BioNTech have been the major winners in the rollout of the shots. It then changed its policy in March, now only promising not to enforce its patents in ways that will harm low-and-middle income nations. Moderna had previously chosen not to enforce its patent during the rollout of the Covid vaccines in an effort to avoid stifling global jab rates. Moderna alleges that the two competing firms copied technology it had patented between 20. Both Moderna's shot and the joint Pfizer-BioNTech jab are mRNA shots - a little-used technology before its introduction to the mainstream during the COVID-19 pandemic. Moderna is suing its two major competitors in the market for COVID-19 vaccines, Pfizer and BioNTech, over allegations that the two firms used its patented technology in the development of their mRNA jabs.
0 kommentar(er)
